IN2014DE00554A - - Google Patents
Download PDFInfo
- Publication number
- IN2014DE00554A IN2014DE00554A IN554DE2014A IN2014DE00554A IN 2014DE00554 A IN2014DE00554 A IN 2014DE00554A IN 554DE2014 A IN554DE2014 A IN 554DE2014A IN 2014DE00554 A IN2014DE00554 A IN 2014DE00554A
- Authority
- IN
- India
- Prior art keywords
- relates
- present
- phoshpoinositide
- pi3k
- anticancer
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 230000001093 anti-cancer Effects 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 210000000481 breast Anatomy 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 201000001441 melanoma Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 210000002307 prostate Anatomy 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IN2015/000088 WO2015128873A1 (en) | 2014-02-27 | 2015-02-16 | "6-aryl-4-phenylamino-quinazoline analogs as phosphoinositide-3-kinase inhibitors" |
| EP15720483.5A EP3110801B1 (en) | 2014-02-27 | 2015-02-16 | 6-aryl-4-phenylamino-quinazoline analogs as phosphoinositide-3-kinase inhibitors |
| CA2940412A CA2940412C (en) | 2014-02-27 | 2015-02-16 | 6-aryl-4-phenylamino-quinazoline analogs as phosphoinositide-3-kinase inhibitors |
| IN554DE2014 IN2014DE00554A (enrdf_load_stackoverflow) | 2014-02-27 | 2015-02-16 | |
| US15/121,328 US10202374B2 (en) | 2014-02-27 | 2015-02-16 | 6-aryl-4-phenylamino-quinazoline analogs as phosphoinositide-3-kinase inhibitors |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN554DE2014 IN2014DE00554A (enrdf_load_stackoverflow) | 2014-02-27 | 2015-02-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DE00554A true IN2014DE00554A (enrdf_load_stackoverflow) | 2015-08-28 |
Family
ID=53051870
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN554DE2014 IN2014DE00554A (enrdf_load_stackoverflow) | 2014-02-27 | 2015-02-16 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US10202374B2 (enrdf_load_stackoverflow) |
| EP (1) | EP3110801B1 (enrdf_load_stackoverflow) |
| CA (1) | CA2940412C (enrdf_load_stackoverflow) |
| IN (1) | IN2014DE00554A (enrdf_load_stackoverflow) |
| WO (1) | WO2015128873A1 (enrdf_load_stackoverflow) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105237484B (zh) * | 2015-09-28 | 2018-12-07 | 西安交通大学 | 一种6-芳基取代的喹啉类化合物及其应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9424233D0 (en) * | 1994-11-30 | 1995-01-18 | Zeneca Ltd | Quinazoline derivatives |
| GB9603095D0 (en) * | 1996-02-14 | 1996-04-10 | Zeneca Ltd | Quinazoline derivatives |
| US9259426B2 (en) | 2006-07-20 | 2016-02-16 | Gilead Sciences, Inc. | 4,6-di- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections |
| UY31137A1 (es) * | 2007-06-14 | 2009-01-05 | Smithkline Beecham Corp | Derivados de quinazolina como inhibidores de la pi3 quinasa |
| SG10201404886PA (en) * | 2009-08-17 | 2014-10-30 | Intellikine Llc | Heterocyclic compounds and uses thereof |
| HK1202333A1 (en) * | 2011-11-11 | 2015-09-25 | Intellikine, Llc | Combination of kinase inhibitors and uses thereof |
-
2015
- 2015-02-16 IN IN554DE2014 patent/IN2014DE00554A/en unknown
- 2015-02-16 WO PCT/IN2015/000088 patent/WO2015128873A1/en active Application Filing
- 2015-02-16 EP EP15720483.5A patent/EP3110801B1/en active Active
- 2015-02-16 US US15/121,328 patent/US10202374B2/en active Active
- 2015-02-16 CA CA2940412A patent/CA2940412C/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2015128873A1 (en) | 2015-09-03 |
| US20170015662A1 (en) | 2017-01-19 |
| EP3110801B1 (en) | 2019-01-30 |
| EP3110801A1 (en) | 2017-01-04 |
| WO2015128873A9 (en) | 2015-12-03 |
| US10202374B2 (en) | 2019-02-12 |
| CA2940412C (en) | 2022-07-12 |
| WO2015128873A4 (en) | 2016-01-28 |
| CA2940412A1 (en) | 2015-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12020551760A1 (en) | Pyridazinones as parp7 inhibitors | |
| MX2020013649A (es) | Composiciones y metodos para inhibir la actividad de la arginasa. | |
| PH12018502535A1 (en) | Substituted carbonucleoside derivatives useful as anticancer agents | |
| MX2020010496A (es) | Inhibidores de desmetilasa-1 especifica de lisina. | |
| PH12022551082A1 (en) | Compositions and methods for inhibiting arginase activity | |
| MX381597B (es) | Inhibidores demetilasa-1 específica de lisina. | |
| MX376632B (es) | Inhibidores de demetilasa-1 especifica de lisina. | |
| MX395534B (es) | Inhibidores de demetilasa-1 especifica de lisina. | |
| EA201790082A1 (ru) | Ингибиторы лизин-специфической демитилазы-1 | |
| TW201613882A (en) | Histone demethylase inhibitors | |
| MX2017003464A (es) | Inhibidores de histona desmetilasa. | |
| SA519410320B1 (ar) | مركبات فينيل -2-هيدروكسي-أسيتيل أمينو -2-ميثيل-فينيل | |
| MX379271B (es) | Compuestos desestabilizadores de microtubulina para usarse en el tratamiento del cáncer. | |
| MY178390A (en) | Inhibitors of iap | |
| MX2013002155A (es) | Compuestos para el tratamiento de cancer. | |
| WO2019023315A3 (en) | RAC INHIBITORS | |
| EA201790604A1 (ru) | Ингибиторы гистондеметилазы | |
| IN2014DE00554A (enrdf_load_stackoverflow) | ||
| WO2015057737A3 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF VprBP-RELATED CANCERS | |
| PH12017501147A1 (en) | Total synthesis of trioxacarcin dc-45-a2 and preparation of trioxacarcin analogs | |
| GB2553684A8 (en) | Ethynylxanthines, preparation and use for cancer treatment |